License pre-approval forthcoming

Application deadlines for stage one of the licensing process have passed, and the Natalie M. LaPrade Maryland Medical Cannabis Commission (the Commission) will no longer be accepting submissions from individuals intending to grow, process, or dispense medical marijuana in the state of Maryland.

A total of 1081 applications were submitted to the Commission, of which there were:

811 dispensary

146 cultivating

124 processing

The Commission originally planned to begin pre-approving licenses early first quarter 2016, but due to the high volume of applications, the timeline has been extended.

Towson University’s Regional Economic Studies Institute (RESI) will evaluate and rank the applications according to the scoring criteria in the state’s regulations. The Commission will pre-approve two dispensing licenses in each senatorial district; 15 growing licenses for the entire state; and an unlimited number of processing licenses.

Contact Green Rush Consulting to begin preparing for stage two of the Maryland medical marijuana licensing process. From reviewing real estate selection and build-out to developing written standard operating procedures to exceeding compliance standards across the board, our experts are ready to help.

Key Dates

The Commission now plans to stagger Stage One license approval, awarding licenses for growers and processors first. This lead-in time will allow approved growers and producers to establish product lines for the anticipated demand of qualifying patients in Maryland.

2016: the Commission intends to announce a timeline for dispensary applications.

Summer 2016: the Commission will begin announcing stage one approvals for growers and processors on a rolling basis beginning summer 2016.

The Commission Chairman Dr. Paul W. Davies commented that proactive applicants are already finalizing stage two licensing requirements, such as real estate zoning approval and installation of equipment, which will expedite the availability of medicinal marijuana for patients.

No Comments Yet.

Leave a comment

*